|
Name |
Ethyl heptadecanoate
|
| Molecular Formula | C19H38O2 | |
| IUPAC Name* |
ethyl heptadecanoate
|
|
| SMILES |
CCCCCCCCCCCCCCCCC(=O)OCC
|
|
| InChI |
InChI=1S/C19H38O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19(20)21-4-2/h3-18H2,1-2H3
|
|
| InChIKey |
KNXMUFRWYNVISA-UHFFFAOYSA-N
|
|
| Synonyms |
Ethyl heptadecanoate; 14010-23-2; ETHYL MARGARATE; Heptadecanoic acid, ethyl ester; Heptadecanoic Acid Ethyl Ester; Ethyl n-heptadecanoate; Margaric Acid Ethyl Ester; Ethylheptadecanoate; EINECS 237-822-6; MFCD00026658; SCHEMBL346642; n-Heptadecanoic acid ethyl ester; Ethyl heptadecanoate, AldrichCPR; DTXSID10161232; NSC137831; ZINC70454038; AKOS015839865; NSC 137831; NSC-137831; AS-60563; DB-042506; CS-0185611; FT-0636996; H0526; H11957; A807621; J-007354
|
|
| CAS | 14010-23-2 | |
| PubChem CID | 26397 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 298.5 | ALogp: | 8.4 |
| HBD: | 0 | HBA: | 2 |
| Rotatable Bonds: | 17 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
| Heavy Atoms: | 21 | QED Weighted: | 0.244 |
| Caco-2 Permeability: | -4.81 | MDCK Permeability: | 0.00001550 |
| Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.883 |
| 30% Bioavailability (F30%): | 0.997 |
| Blood-Brain-Barrier Penetration (BBB): | 0.108 | Plasma Protein Binding (PPB): | 97.44% |
| Volume Distribution (VD): | 2.402 | Fu: | 1.46% |
| CYP1A2-inhibitor: | 0.381 | CYP1A2-substrate: | 0.185 |
| CYP2C19-inhibitor: | 0.441 | CYP2C19-substrate: | 0.062 |
| CYP2C9-inhibitor: | 0.187 | CYP2C9-substrate: | 0.937 |
| CYP2D6-inhibitor: | 0.216 | CYP2D6-substrate: | 0.039 |
| CYP3A4-inhibitor: | 0.318 | CYP3A4-substrate: | 0.062 |
| Clearance (CL): | 4.519 | Half-life (T1/2): | 0.197 |
| hERG Blockers: | 0.269 | Human Hepatotoxicity (H-HT): | 0.011 |
| Drug-inuced Liver Injury (DILI): | 0.249 | AMES Toxicity: | 0.005 |
| Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.012 |
| Skin Sensitization: | 0.958 | Carcinogencity: | 0.052 |
| Eye Corrosion: | 0.964 | Eye Irritation: | 0.962 |
| Respiratory Toxicity: | 0.9 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000258 | ![]() |
0.952 | D07ILQ | ![]() |
0.667 | ||
| ENC000419 | ![]() |
0.950 | D00FGR | ![]() |
0.552 | ||
| ENC000496 | ![]() |
0.828 | D00AOJ | ![]() |
0.549 | ||
| ENC000280 | ![]() |
0.818 | D0Z5SM | ![]() |
0.541 | ||
| ENC001218 | ![]() |
0.800 | D0O1PH | ![]() |
0.500 | ||
| ENC001234 | ![]() |
0.791 | D05ATI | ![]() |
0.466 | ||
| ENC000497 | ![]() |
0.783 | D00MLW | ![]() |
0.455 | ||
| ENC000271 | ![]() |
0.781 | D00STJ | ![]() |
0.403 | ||
| ENC000356 | ![]() |
0.754 | D0G2KD | ![]() |
0.402 | ||
| ENC000474 | ![]() |
0.750 | D0T9TJ | ![]() |
0.398 | ||